Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Brivudine

EU orphan designation number: EU/3/09/703   
Active ingredient: Brivudine
Indication: Treatment of pancreatic cancer
Sponsor: RESprotect GmbH
Fiedlerstraße 34, 01307 Dresden, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
1/02/2010 Orphan designation EMEA/OD/105/09 (2010)661 of 28/01/2010